These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28324032)

  • 21. Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.
    Lagrou K; Froidecoeur C; Thomas M; Massa G; Beckers D; Craen M; de Beaufort C; Rooman R; François I; Heinrichs C; Lebrethon MC; Thiry-Counson G; Maes M; De Schepper J
    Horm Res; 2008; 69(6):334-42. PubMed ID: 18504392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Campos A; Albisu MA; Clemente M; Bel J; Nosás R; Rabanal M; Del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2013; 79():145-56. PubMed ID: 23548791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.
    Boguszewski MC; Lindberg A; Wollmann HA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2683-8. PubMed ID: 24758180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Results of GH Treatment in Silver-Russell Syndrome (SRS): Do They Benefit the Same as Non-SRS Short-SGA?
    Smeets CC; Zandwijken GR; Renes JS; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2105-12. PubMed ID: 27007691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
    van der Steen M; Lem AJ; van der Kaay DC; Bakker-van Waarde WM; van der Hulst FJ; Neijens FS; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment.
    Willemsen RH; van Dijk M; de Kort SW; van Toorenenbergen AW; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):264-8. PubMed ID: 18284641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
    Ranke MB; Lindberg A
    Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
    Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
    Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
    Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
    Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood.
    Poidvin A; Touzé E; Ecosse E; Landier F; Béjot Y; Giroud M; Rothwell PM; Carel JC; Coste J
    Neurology; 2014 Aug; 83(9):780-6. PubMed ID: 25122206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB; Martin DD; Ehehalt S; Schwarze CP; Serra F; Wollmann HA; Schweizer R
    Horm Res Paediatr; 2011; 76(2):104-12. PubMed ID: 21757866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone treatment of short children born small for gestational age: a US perspective.
    Chernausek SD
    Horm Res; 2004; 62 Suppl 3():124-7. PubMed ID: 15539813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.